171 related articles for article (PubMed ID: 24488015)
1. New molecular staging with G-factor supplements TNM classification in gastric cancer: a multicenter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committee.
Sawada T; Yashiro M; Sentani K; Oue N; Yasui W; Miyazaki K; Kai K; Fushida S; Fujimura T; Ohira M; Kakeji Y; Natsugoe S; Shirabe K; Nomura S; Shimada Y; Tomita N; Hirakawa K; Maehara Y
Gastric Cancer; 2015 Jan; 18(1):119-28. PubMed ID: 24488015
[TBL] [Abstract][Full Text] [Related]
2. New molecular staging with G-factors (VEGF-C and Reg IV) by supplementing TNM classification in colorectal cancers.
Sawada T; Yashiro M; Sentani K; Oue N; Yasui W; Miyazaki K; Kai K; Fujita H; Nakamura K; Maeda K; Kakeji Y; Natsugoe S; Shirabe K; Nomura S; Shimada Y; Tomita N; Hirakawa K; Maehara Y
Oncol Rep; 2013 Dec; 30(6):2609-16. PubMed ID: 24101199
[TBL] [Abstract][Full Text] [Related]
3. Correlation of vascular endothelial growth factor expression with tumor recurrence and poor prognosis in patients with pN0 gastric cancer.
Liu YF; Guo S; Zhao R; Chen YG; Wang XQ; Xu KS
World J Surg; 2012 Jan; 36(1):109-17. PubMed ID: 21773953
[TBL] [Abstract][Full Text] [Related]
4. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
5. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer.
Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS
World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771
[TBL] [Abstract][Full Text] [Related]
6. Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma.
Lee J; Kang WK; Park JO; Park SH; Park YS; Lim HY; Kim J; Kong J; Choi MG; Sohn TS; Noh JH; Bae JM; Kim S; Lim DH; Kim KM; Park CK
APMIS; 2009 Aug; 117(8):598-606. PubMed ID: 19664131
[TBL] [Abstract][Full Text] [Related]
7. High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients.
Chen J; Tang D; Wang S; Li QG; Zhang JR; Li P; Lu Q; Niu G; Gao J; Ye NY; Wang DR
Tumour Biol; 2014 Mar; 35(3):2513-9. PubMed ID: 24241899
[TBL] [Abstract][Full Text] [Related]
8. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
9. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer.
Kim YJ; Kim MA; Im SA; Kim TM; Kim DW; Yang HK; Heo DS; Lee KU; Choe KJ; Kim NK; Kim TY; Kim WH; Bang YJ
Cancer Invest; 2008 Mar; 26(2):152-8. PubMed ID: 18259945
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer.
Zhou Y; Li G; Wu J; Zhang Z; Wu Z; Fan P; Hao T; Zhang X; Li M; Zhang F; Li Q; Lu B; Qiao L
Tumour Biol; 2010 Dec; 31(6):549-58. PubMed ID: 20563765
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
12. The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma.
Han FH; Li HM; Zheng DH; He YL; Zhan WH
Eur J Surg Oncol; 2010 Dec; 36(12):1172-9. PubMed ID: 20888167
[TBL] [Abstract][Full Text] [Related]
13. Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer.
Cho JH; Lim JY; Cho JY
World J Gastroenterol; 2017 Nov; 23(41):7407-7414. PubMed ID: 29151694
[TBL] [Abstract][Full Text] [Related]
14. Association of HER2 status with prognosis in gastric cancer patients undergoing R0 resection: A large-scale multicenter study in China.
Shen GS; Zhao JD; Zhao JH; Ma XF; Du F; Kan J; Ji FX; Ma F; Zheng FC; Wang ZY; Xu BH
World J Gastroenterol; 2016 Jun; 22(23):5406-14. PubMed ID: 27340357
[TBL] [Abstract][Full Text] [Related]
15. The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
Fanelli MF; Chinen LT; Begnami MD; Costa WL; Fregnami JH; Soares FA; Montagnini AL
Histopathology; 2012 Aug; 61(2):153-61. PubMed ID: 22582975
[TBL] [Abstract][Full Text] [Related]
16. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
Wang XL; Fang JP; Tang RY; Chen XM
BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.
Gao XH; Yang XQ; Wang BC; Liu SP; Wang FB
Asian Pac J Cancer Prev; 2013; 14(9):5055-60. PubMed ID: 24175775
[TBL] [Abstract][Full Text] [Related]
18. CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients.
Cao Y; Liu H; Zhang H; Lin C; Li R; Wu S; Li H; He H; Zhang W; Xu J
Oncotarget; 2017 Mar; 8(12):20328-20339. PubMed ID: 27780937
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
20. High Tumor Vascular Endothelial Growth Factor Expression Is Associated With Poorer Clinical Outcomes in Resected T3 Gastric Adenocarcinoma.
Lin C; Zhang Z; Xu Y; Wang R; Chen S; Gao J; Wang D; Huang Q; Tu X; Wang L
Am J Clin Pathol; 2016 Sep; 146(3):278-88. PubMed ID: 27543975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]